<DOC>
	<DOCNO>NCT01028521</DOCNO>
	<brief_summary>A first time man , phase I study assess safety , tolerability pharmacokinetics single ascend dos CM3.1-AC100 healthy male volunteer .</brief_summary>
	<brief_title>First Man Clinical Study Investigate Safety , Tolerability Pharmacokinetics Single Ascending Doses CM3.1-AC100</brief_title>
	<detailed_description />
	<criteria>Provision sign date informed consent prior study specific procedure Body weight 60.0 100.0 kg ( inclusive ) BMI 19 29.9 kg/m2 ( inclusive ) Judged healthy comprehensive clinical assessment ( detailed medical history complete physical examination ) Any history presence clinically relevant disease judge relevant Investigator Blood donation within 3 month administration IP Have history hypersensitivity IP excipients medicinal product similar chemical structure</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>50 Years</maximum_age>
	<verification_date>July 2010</verification_date>
	<keyword>First time man , safety study , Cm3.1-AC100</keyword>
	<keyword>Male volunteer age 18 50 year Screening</keyword>
</DOC>